An Australian Community-Based Metabolic Dysfunction-Associated Steatotic Liver Disease Care Pathway for People with Type 2 Diabetes: Barriers and Considerations

Gracen L, Aikebuse M, Sarraf B, McPhail SM, Russell AW, O’Beirne J, Irvine KM, Williams S, Valery PC, Powell EE

Patient Preference and Adherence 2024, 18:1845-1855

Published Date: 9 September 2024